VistaGen Therapeutics, Inc. (VTGN) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $0.63 (+2.71%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 17, 2025 | Andrew Tsai | Jefferies | $0.90 | +42.9% |
| Nov 17, 2025 | Paul Mattheis | Stifel Nicolaus | $12.00 | +1804.8% |
| Jul 22, 2022 | Andrew Tsai | Jefferies | $6.00 | +852.4% |
Top Analysts Covering VTGN
VTGN vs Sector & Market
| Metric | VTGN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 18 |
| Target Upside | +50.8% | +1150.2% | +14.9% |
| P/E Ratio | -0.38 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-03-31 | $1M | $1M | $1M | 3 |
| 2028-03-31 | $7M | $7M | $7M | 3 |
| 2029-03-31 | $20M | $20M | $20M | 2 |
| 2030-03-31 | $80M | $80M | $80M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-03-31 | $-1.19 | $-1.10 | $-1.00 | 3 |
| 2028-03-31 | $-2.33 | $-1.53 | $-1.03 | 3 |
| 2029-03-31 | $-3.67 | $-0.74 | $2.19 | 2 |
| 2030-03-31 | $-0.56 | $-0.56 | $-0.56 | 1 |
Frequently Asked Questions
What is the analyst consensus for VTGN?
The consensus among 3 analysts covering VistaGen Therapeutics, Inc. (VTGN) is Hold with an average price target of $0.95.
What is the highest price target for VTGN?
The highest price target for VTGN is $12.00, set by Paul Mattheis at Stifel Nicolaus on 2025-11-17.
What is the lowest price target for VTGN?
The lowest price target for VTGN is $0.90, set by Andrew Tsai at Jefferies on 2025-12-17.
How many analysts cover VTGN?
3 analysts have issued ratings for VistaGen Therapeutics, Inc. in the past 12 months.
Is VTGN a buy or sell right now?
Based on 3 analyst ratings, VTGN has a consensus rating of Hold (3.00/5) with a +50.8% upside to the consensus target of $0.95.
What are the earnings estimates for VTGN?
Analysts estimate VTGN will report EPS of $-1.10 for the period ending 2027-03-31, with revenue estimated at $1M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.